Clinical trialNCT02347111RecruitingPhase 4Interventional

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

SponsorUniversity of Illinois at ChicagoEnrollment162Atrial Fibrillation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In this pilot and feasibility study, the investigators will enroll patients with frequent symptomatic episodes of atrial fibrillation (AF) in a cross-over study testing two different classes of anti arrhythmic drugs (AADs). This pilot and feasibility study will provide preliminary data for a larger study in which the investigators will test the hypothesis that a common AF genetic risk allele modulates response to different AADs.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Jesse Brown Va Medical Center
Chicago, Illinois, United States
Sorin Lazar, MD
Not, yet, recruiting
Rush University Medical Center
Chicago, Illinois, United States
Henry Huang, MD
Not, yet, recruiting
University of Illinois at Chicago
Chicago, Illinois, United States
Dawood Darbar, M.D.
Recruiting
Advocate Christ Medical Center
Oak Lawn, Illinois, United States
Adarsh Bhan, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Flecainide →Sotalol →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2020
Primary completion: 30 Jun 2026
Completion: 30 Jun 2026
Last update posted: 24 Aug 2025
Registered enrollment: 162
Registry id: NCT02347111

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.